Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative senescence

Cell Proliferation

Volumn 47, Issue 3, 2014, Pages 267-276

  Poleszczuk, J ^a,b   Hahnfeldt, P ^a   Enderling, H ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WARSAW   (Poland)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER INHIBITION; CANCER RISK; CANCER STEM CELL; CELL DAMAGE; CELL DEATH; CELL TYPE; CONCEPTUAL FRAMEWORK; DYNAMICS; GENE ACTIVATION; MALIGNANT TRANSFORMATION; MITOSIS; ONCOGENE; SENESCENCE; SIMULATION; SOLID TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ALGORITHMS; APOPTOSIS; CELL AGING; CELL PROLIFERATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 84900016993     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12101     Document Type: Article

References (71)

1. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621.
2. Campisi J, D'adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740.
3. Kondoh H, Maruyama T, Lleonart ME (2008) Senescence as a target for cancer therapy. Open Pathol. 2, 57-62.
4. Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413.
5. Blackburn EH, Gall JG (1978) A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J. Mol. Biol. 120, 33-53.
6. Serrano M, Blasco MA (2001) Putting the stress on senescence. Curr. Opin. Cell Biol. 13, 748-753.
7. Serrano M, Lin AW, Mccurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.
8. Chen Z, Trotman LC, Shaffer D, Lin H-K, Dotan ZA, Niki M et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumourigenesis. Nat. Cell Biol. 436, 725-730.
9. Campisi J (1997) The biology of replicative senescence. Eur. J. Cancer 33, 703-709.
10. Rodier F, Campisi J (2011) Four faces of cellular senescence. J. Cell Biol. 192, 547-556.
11. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M et al. (2005) Tumour biology: senescence in premalignant tumours. Nature 436, 642.
12. Lynch MD (2006) How does cellular senescence prevent cancer? DNA Cell Biol. 25, 69-78.
13. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57-70.
14. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
15. Lleonart ME, Artero-Castro A, Kondoh H (2009) Senescence induction: a possible cancer therapy. Mol. Cancer 8, 3.
16. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM et al. (2002) A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335-346.
17. Wu C-H, van Riggelen J, Yetil A, Fan AC, Bachireddy P, Felsher DW (2007) Cellular senescence is an important mechanism of tumour regression upon c-Myc inactivation. Proc. Natl. Acad. Sci. USA 104, 13028-13033.
18. Nardella C, Clohessy JG, Alimonti A, Pandolfi PP (2011) Pro-senescence therapy for cancer treatment. Nat. Rev. Cancer 11, 503-511.
19. Ewald JA, Desotelle JA, Wilding G, Jarrard DF (2010) Therapy-Induced Senescence in Cancer. J. Natl. Cancer Inst. 102, 1536-1546.
20. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
21. Dick JE (2008) Stem cell concepts renew cancer research. Blood 112, 4793-4807.
22. Roberts SA, Hendry JH (1993) The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data. Radiother. Oncol. 29, 69-74.
23. Schmidt-Ullrich RK, Contessa JN, Dent P, Mikkelsen RB, Valerie K, Reardon DB et al. (1999) Molecular mechanisms of radiation-induced accelerated repopulation. Radiat. Oncol. Investig. 7, 321-330.
24. Black WC, Welch HG (1993) Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N. Engl. J. Med. 328, 1237-1243.
25. Folkman J, Kalluri R (2004) Cancer without disease. Nature 427, 787.
26. Welch HG, Black WC (2010) Overdiagnosis in Cancer. J. Natl. Cancer Inst. 102, 605-613.
27. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. (2003) Identification of a cancer stem cell in human brain tumours. Cancer Res. 63, 5821-5828.
28. Baumann M, Krause M, Hill R (2008) Exploring the role of cancer stem cells in radioresistance. Nat. Rev. Cancer 8, 545-554.
29. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768.
30. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumourigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988.
31. Morrison SJ, Kimble J (2006) Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441, 1068-1074.
32. Caussinus E, Hirth F (2007) Asymmetric stem cell division in development and cancer. Prog. Mol. Subcell. Biol. 45, 205-225.
33. Enderling H, Anderson ARA, Chaplain MAJ, Beheshti A, Hlatky L, Hahnfeldt P (2009) Paradoxical dependencies of tumour dormancy and progression on basic cell kinetics. Cancer Res. 69, 8814-8821.
34. Bao S, Wu Q, Mclendon RE, Hao Y, Shi Q, Hjelmeland AB et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760.
35. Enderling H, Chaplain MAJ, Hahnfeldt P (2010) Quantitative modeling of tumour dynamics and radiotherapy. Acta. Biotheor. 58, 341-353.
36. Roninson IB (2003) Tumour cell senescence in cancer treatment. Cancer Res. 63, 2705-2715.
37. Buijs JOD, van den Bosch PPJ, Musters MWJM, van Riel NAW (2004) Mathematical modeling confirms the length-dependency of telomere shortening. Mech. Ageing Dev. 125, 437-444.
38. Karpinets TV, Foy BD (2004) Model of the developing tumourigenic phenotype in mammalian cells and the roles of sustained stress and replicative senescence. J. Theor. Biol. 227, 253-264.
39. Wang Y, Aguda BD, Friedman A (2007) A continuum mathematical model of endothelial layer maintenance and senescence. Theor. Biol. Med. Model. 4, 30.
40. Wodarz D (2007) Effect of stem cell turnover rates on protection against cancer and aging. J. Theor. Biol. 245, 449-458.
41. Mitteldorf J, Pepper J (2009) Senescence as an adaptation to limit the spread of disease. J. Theor. Biol. 260, 186-195.
42. Marciniak-Czochra A, Stiehl T, Wagner W (2009) Modeling of replicative senescence in hematopoietic development. Aging (Albany NY) 1, 723-732.
43. La Porta CAM, Zapperi S, Sethna JP (2012) Senescent cells in growing tumours: population dynamics and cancer stem cells. PLoS Comput. Biol. 8, e1002316.
44. Enderling H, Hlatky L, Hahnfeldt P (2009) Migration rules: tumours are conglomerates of self-metastases. Br. J. Cancer 100, 1917-1925.
45. Deutsch A, Dormann S (2005) Cellular Automaton Modeling of Biological Pattern Formation: Characterization, Applications, and Analysis. Boston, MA: Birkhäuser.
46. Anderson ARA, Chaplain MAJ, Rejniak KA (2009) Single-Cell-Based Models in Biology and Medicine. Basel, Switzerland: Birkhäuser.
47. Rejniak KA (2007) An immersed boundary framework for modelling the growth of individual cells: an application to the early tumour development. J. Theor. Biol. 247, 186-204.
48. Alarcón T, Byrne HM, Maini PK (2003) A cellular automaton model for tumour growth in inhomogeneous environment. J. Theor. Biol. 225, 257-274.
49. Gerlee P, Anderson ARA (2007) An evolutionary hybrid cellular automaton model of solid tumour growth. J. Theor. Biol. 246, 583-603.
50. Wang Z, Zhang L, Sagotsky J, Deisboeck TS (2007) Simulating non-small cell lung cancer with a multiscale agent-based model. Theor. Biol. Med. Model. 4, 50.
51. Basanta D, Simon M, Hatzikirou H, Deutsch A (2008) Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion. Cell Prolif. 41, 980-987.
52. Enderling H, Alexander NR, Clark ES, Branch KM, Estrada L, Crooke C et al. (2008) Dependence of invadopodia function on collagen fiber spacing and cross-linking: computational modeling and experimental evidence. Biophys. J. 95, 2203-2218.
53. Piotrowska MJ, Angus SD (2009) A quantitative cellular automaton model of in vitro multicellular spheroid tumour growth. J. Theor. Biol. 258, 165-178.
54. Mukhopadhyay R, Costes SV, Bazarov AV, Hines WC, Barcellos-Hoff M, Yaswen P (2010) Promotion of variant human mammary epithelial cell outgrowth by ionizing radiation: an agent-based model supported by in vitro studies. Breast Cancer Res. 12, R11.
55. Tang J, Enderling H, Becker-Weimann S, Pham C, Polyzos A, Chen C-Y et al. (2011) Phenotypic transition maps of 3D breast acini obtained by imaging-guided agent-based modeling. Integr. Biol. 3, 408.
56. Power C (2009) A spatial agent-based model of n-person Prisoner's Dilemma cooperation in a socio-geographic community. J. Artif. Soc. Soc. Sim. 12, 8.
57. Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636.
58. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A et al. (2011) miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 193, 409-424.
59. Korybalska K, Kawka E, Kusch A, Aregger F, Dragun D, Jorres A et al. (2013) Recovery of senescent endothelial cells from injury. J. Gerontol. A Biol. Sci. Med. Sci. 68, 250-257.
60. Gao X, Mcdonald JT, Hlatky L, Enderling H (2013) Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res. 73, 1481-1490.
61. Jin S, Dipaola RS, Mathew R, White E (2007) Metabolic catastrophe as a means to cancer cell death. J. Cell Sci. 120, 379-383.
62. Enderling H, Park D, Hlatky L, Hahnfeldt P (2009) The importance of spatial distribution of stemness and proliferation state in determining tumour radioresponse. Math. Model. Nat. Phenom. 4, 117-133.
63. Enderling H, Hlatky L, Hahnfeldt P (2010) Tumour morphological evolution: directed migration and gain and loss of the self-metastatic phenotype. Biol. Direct 5, 23.
64. Prehn RT (1991) The inhibition of tumour growth by tumour mass. Cancer Res. 51, 2-4.
65. Norton L (2005) Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. Oncologist 10, 370-381.
66. Folkman J, Hochberg M (1973) Self-regulation of growth in three dimensions. J. Exp. Med. 138, 745-753.
67. Roose T, Chapman SJ, Maini PK (2007) Mathematical models of avascular tumour growth. SIAM Rev. 49, 179-208.
68. Jeyapalan JC, Sedivy JM (2008) Cellular senescence and organismal aging. Mech. Ageing Dev. 129, 467-474.
69. Parrinello S (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118, 485-496.
70. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660.
71. Davalos AR, Coppe J-P, Campisi J, Desprez P-Y (2010) Senescent cells as a source of inflammatory factors for tumour progression. Cancer Metastasis Rev. 29, 273-283.